Home - Product - Newcastle Disease, Infectious Bronchitis,Avian Influenza (Subtype H9) And Infectious Bursal Disease Four-valent Vaccine, Inactivated

Newcastle Disease, Infectious Bronchitis,Avian Influenza (Subtype H9) And Infectious Bursal Disease Four-valent Vaccine, Inactivated

Generic name of product

Newcastle Disease, Infectious Bronchitis,Avian Influenza (Subtype H9)  And Infectious Bursal Disease Four-valent Vaccine, Inactivated

Main Ingredients and Content

The vaccine contains the inactivated Newcastle Disease Virus (sub-genotype VII) with a viral titer of ≥ 3×109.0EID50/0.1ml (before inactivation), Infectious Bronchitis virus strain QX (the content before inactivation ≥ 1×107.5EID50/0.1mL),the inactivated Avian Influenza Virus (H9N2 subtype clade 4.1.a and 4.1.b) both with a viral titer of ≥ 3×109.0EID50/0.1ml (before inactivation), the VP2 protein content of Infectious Bursal Disease Virus in is 10μg /0.1 mL.

Character

Milky white uniform emulsion

Functions and Uses

Used for the prevention of Newcastle Disease(sub-genotype VII), Infectious Bronchitis virus strain QX,Avian Influenza (H9N2 subtype clade 4.1.a and 4.1.b) and Infectious Bursal Disease Virus. Immunity is generated 14–21 days after immunization, the duration of immunity is 3 months for young chickens and 6 months for adult chickens

Usage and Dosage

Administer via subcutaneous injection in the neck or intramuscular injection.

For chickens aged 3 weeks: 0.3ml/dose

For chickens over 3 weeks of age: 0.5ml/dose

Adverse Reactions

Generally, no visible adverse reactions occur

Precautions

Storage and Period of Validity

2-8℃ preservation, valid for 24 months.

Specifications

(1)250mL/bottle, 40bottles/carton  (2)500mL/bottle, 20bottles/carton

Only under the guidance of the veterinary use

Features

1.One injection provides four protections – an innovative breakthrough in China that improves disease prevention efficiency, enhances effectiveness, and reduces farm workload.  

2.Serotype-matched, highly concentrated viral subunit antigens formulated in scientifically optimized proportions.  

3.Adjuvant formulation ensures zero stress and delivers high-efficiency protection using compound vegetable oil technology.  

4.The vaccine contains composite antigens from classical very virulent Infectious Bursal Disease virus (cvvIBDV) and novel variant IBDV (nvIBDV), offering improved cross-protection against both strains as an upgraded version of the company’s original inactivated IBD vaccine series.

5.The adoption of a customized H9 Avian Influenza strain model enables meeting the needs of different countries for prevalent strains.

滚动至顶部

Become Wollvac Partner

You will usually receive a response within 2 minutes, and at the latest within 24 hours!